I148M PNPLA3 POLYMORPHISM IS ASSOCIATED WITH CLINICAL FEATURES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

被引：4
|
作者：
Valenti, L. [1 ]
Motta, B. [1 ]
Soardo, G. [2 ]
Bertelli, C. [1 ]
Sangiovanni, A. [1 ]
Rametta, R. [1 ]
Dongiovanni, P. [1 ]
Colombo, M. [1 ]
Fargion, S. [1 ]
Fracanzani, A. L. [1 ]
机构：
[1] Univ Milan, Milan, Italy
[2] Univ Udine, I-33100 Udine, Italy
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)60328-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
315
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [41] PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review
    Boeckmans, Joost
    Gatzios, Alexandra
    Schattenberg, Joern M.
    Koek, Ger H.
    Rodrigues, Robim M.
    Vanhaecke, Tamara
    LIVER INTERNATIONAL, 2023, 43 (05) : 975 - 988
  • [42] Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease
    Valenti, Luca
    Dongiovanni, Paola
    HEPATOLOGY, 2017, 66 (04) : 1026 - 1028
  • [43] Expression of PNPLA3 I148M Variant Alters Lipid Droplet Proteome
    Monetti, Mara
    Culver, Jeffrey
    Sasi, Sharath
    Xue, Liang
    Tesz, Gregory
    Crowley, Collin
    Ross, Trenton
    Magee, Thomas
    Miller, Melissa
    Zhang, Bei
    Bence, Kendra
    MOLECULAR & CELLULAR PROTEOMICS, 2019, 18 (08) : S38 - S38
  • [44] PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease
    Speliotes, Elizabeth K.
    Schneider, Carolin Victoria
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [45] PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients
    Nakaoka, Kazunori
    Hashimoto, Senju
    Kawabe, Naoto
    Nitta, Yoshifumi
    Murao, Michihito
    Nakano, Takuji
    Shimazaki, Hiroaki
    Kan, Toshiki
    Takagawa, Yuka
    Ohki, Masashi
    Kurashita, Takamitsu
    Takamura, Tomoki
    Nishikawa, Toru
    Ichino, Naohiro
    Osakabe, Keisuke
    Yoshioka, Kentaro
    SPRINGERPLUS, 2015, 4
  • [46] Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease
    Huang, Yongcheng
    Cohen, Jonathan C.
    Hobbs, Helen H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (43) : 37085 - 37093
  • [47] Meta-analysis reveals a specific association of the PNPLA3 I148M polymorphism with ALT level in adolescents
    Liu, Zhengtao
    Ning, Huaijun
    He, Xiaoyin
    Que, Shuping
    Zhou, Lin
    PERSONALIZED MEDICINE, 2015, 12 (02) : 67 - 82
  • [48] ASSOCIATION BETWEEN PNPLA3 I148M POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE INDIAN CONTINENT
    Rangegowda, D.
    Sharma, S.
    Kumar, K. N. Chandan
    Maiwal, R.
    Vashista, C.
    Sharma, M. K.
    Bhatia, V.
    Bhadoria, A. S.
    Rastogi, A.
    Sarin, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S748 - S748
  • [49] Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity
    Xin, Yong-Ning
    Zhao, Yuqi
    Lin, Zhong-Hua
    Jiang, Xiangjun
    Xuan, Shi-Ying
    Huang, Jingfei
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2013, 81 (03) : 406 - 414
  • [50] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
    Linden, Daniel
    Ahnmark, Andrea
    Pingitore, Piero
    Ciociola, Ester
    Ahlstedt, Ingela
    Andreasson, Anne-Christine
    Sasidharan, Kavitha
    Madeyski-Bengtson, Katja
    Zurek, Magdalena
    Mancina, Rosellina M.
    Lindblom, Anna
    Bjursell, Mikael
    Bottcher, Gerhard
    Stahlman, Marcus
    Bohlooly-Y, Mohammad
    Haynes, William G.
    Carlsson, Bjorn
    Graham, Mark
    Lee, Richard
    Murray, Sue
    Valenti, Luca
    Bhanot, Sanjay
    Akerblad, Peter
    Romeo, Stefano
    MOLECULAR METABOLISM, 2019, 22 : 49 - 61
12345